Skip to content
MS
PW-017 Amino Acid & Nitrogen Metabolism Catabolic unreviewed

Oxidative Deamination

Glutamate (+ glutamine, asparagine) alpha-Ketoglutarate + NH4+
Compartment
Mitochondrial matrix
Main tissue
Liver, kidney
Rate-limiting
Not flagged in the source
Steps
3

Reaction steps

In source order, 3 total

showing 1–3
  1. 1

    L-glutamate + NAD⁺ (or NADP⁺) + H₂O ⇌ α-ketoglutarate + NH₄⁺ + NADH (or NADPH) + H⁺

    › Notes

    Glutamate dehydrogenase catalyzes oxidative deamination in the mitochondrial matrix. NAD⁺ is generally the major oxidant during net hepatic glutamate oxidation, although the enzyme can use NADP⁺; the reaction is reversible and is the principal regulated route for release of free ammonia from glutamate.

  2. 2

    L-glutamine + H₂O → L-glutamate + NH₄⁺

    Glutaminase 3.5.1.2 ST-0139 Irreversible H2O
    › Notes

    Glutaminase hydrolyzes the amide nitrogen of glutamine in mitochondria; it requires water but no redox cofactor. This irreversible hydrolytic deamidation is not itself oxidative deamination, but it is a major upstream source of mitochondrial glutamate and ammonia in liver, kidney, intestine, and brain.

  3. 3

    L-asparagine + H₂O → L-aspartate + NH₄⁺

    Asparaginase 3.5.1.1 ST-0140 Irreversible H2O
    › Notes

    Asparaginase catalyzes irreversible deamidation, providing a smaller additional source of ammonia. The resulting aspartate can be transaminated to oxaloacetate and glutamate or can donate nitrogen to the urea cycle.

Showing all 3 steps.

Regulation

What speeds each enzyme up and what slows it down

Glutamate dehydrogenase

Accelerated by

ADP, GDP; leucine allosterically activates the mammalian enzyme

Inhibited by

ATP, GTP; high-energy charge

Hormonal

Glucagon and cortisol increase hepatic amino-acid catabolic/ureagenic capacity indirectly; insulin suppresses net amino-acid catabolism in the fed state

Hepatic glutaminase

Accelerated by

Glutamine availability; chronic high-protein intake/acidosis can increase expression

Inhibited by

Product accumulation; reduced demand for ammonia disposal

Hormonal

Glucagon can support hepatic ureagenic flux; regulation is largely transcriptional and substrate-driven

Renal glutaminase

Accelerated by

Acidosis, glutamine availability

Inhibited by

Alkalosis reduces net ammoniagenic drive

Hormonal

Cortisol supports renal ammoniagenesis; acid–base status is the dominant physiological regulator

Overview

Oxidative deamination releases the amino nitrogen of glutamate as ammonium while regenerating α-ketoglutarate. In the liver this provides mitochondrial ammonia for carbamoyl phosphate synthesis and the urea cycle; in kidney, ammonium production contributes to acid excretion. Coupling transamination to glutamate dehydrogenase creates the classic transdeamination route by which nitrogen from many amino acids is ultimately disposed of.

Cellular location

Glutamate dehydrogenase (GDH/GLUD) is a mitochondrial matrix enzyme, especially active in liver and kidney and present in brain and other oxidative tissues. Mitochondrial localization places generated NH₄⁺ adjacent to carbamoyl phosphate synthetase I in hepatocytes.

Net energetics

For net GDH oxidation with NAD⁺, one glutamate yields 1 NADH and one NH₄⁺, with no ATP consumed. If NADP⁺ is the acceptor, the reaction yields 1 NADPH instead; subsequent oxidative phosphorylation of NADH can capture energy if reducing equivalents are reoxidized.

Clinical significance

Free ammonia is neurotoxic, so oxidative deamination is tightly coupled to urea synthesis in periportal hepatocytes or to renal ammonium excretion. Activating GLUD1 variants cause hyperinsulinism/hyperammonemia syndrome, partly because leucine-stimulated GDH promotes insulin secretion and excess ammonia generation. Conversely, impaired hepatic ammonia detoxification in severe liver disease produces hyperammonemia and can contribute to hepatic encephalopathy.

Recent literature

Live Europe PMC search

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Systemic Copper Chelation Reduces Collagen Deposition and Preserves Secretory Function in Irradiated Mouse Salivary Glands.

    Nam K, Maslow FM, Santos HTD, Shanbhag VC, Osorio RA, Petris MJ, Baker OJ. · 2026-07-22

    open access unreviewed
  2. 2
    Efficacy of tannins as silage additives to inhibit deamination process during ensiling: a meta-analysis and <i>in silico</i> approach.

    Susanto I, Mahendra FR, Azzahra FR, Rahmadani M, Ridwan R, Wiryawan KG, Laconi EB, Jayanegara A. · 2026-06-15

    cited 1× open access unreviewed
  3. 3
    The nucleus as a mechanobiological hub in muscle aging.

    Esen O, Battey E, Stroud MJ, Kirby TJ. · 2026-06-18

    cited 1× open access unreviewed
  4. 4
    The protease code of the bacterial gut microbiota: ecological regulation, barrier disruption, and rewiring host defense and signaling.

    Eckhard U, Ramírez-Larrota JS, Estevan-Morió E, Gomis-Rüth FX. · 2026-06-10

    open access unreviewed
  5. 5
    Research progress in metabolic reprogramming and targeting metabolic pathways for clear cell renal cell carcinoma.

    Yao JT, Hu PC, Li XW, Xu JC, Wang KJ, Ye SZ, Meng XY, Chen HC, Liang Y, Ma Q. · 2025-12-19

    open access unreviewed
  6. 6
    Iron and Other Metal Ions in Human Health and Disease.

    Dai X, Li J. · 2026-10-02

    open access unreviewed
  7. 7
    Exploring the Neuropharmacological Potential of Ligustrum sinense Relevant to Parkinson's Disease: In Vivo and In Silico Study.

    Das S, Hamim SMI, Zilani MNH, Chhando KS, Das P, Hossain MR, Imtiaz M, Tasmin J, Miah R, Hasan MN. · 2026-10-01

    open access unreviewed
  8. 8
    Glutamine Metabolism in Health and Diseases.

    Ding Y, Tong F, Zeng J, Cui CP. · 2026-09-29

    open access unreviewed
  9. 9
    Two distinct alcohol dehydrogenase classes mediate bacterial 2-hydroxyethylphosphonate catabolism.

    Piazza F, Rodella M, Salanti N, Merici G, Rossi E, Rivetti C, Götzinger F, Pallitsch K, Peracchi A. · 2026-10-01

    cited 1× open access unreviewed
  10. 10
    An Integrated in Silico, in Vitro, and in Vivo Assessment of the Antioxidant and Neuroprotective Profile of Selenocyanate Compounds.

    da Rocha MER, Pizzi BR, da Costa P, Hall TK, Paim MP, Cordeiro P, Menezes V, Nascimento V, Brüning CA, Birman… · 2026-07-31

    open access unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.